This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: Targeted Anticancer Drugs and Immunosuppressants, Subject name: Pharmacology
Which of the following statements about baricitinib is FALSE? 
Select and explain. 
A. Oral JAK inhibitor, B. Approved for use in moderate to severe Crohn's disease, C. Increases triglycerides, D. Dose reduction is required in renal and hepatic impairement
B: Approved for use in moderate to severe Crohn's disease
Answer: B: Approved for use in moderate to severe Crohn's disease 
Explanation: Baricitinib andtofacitinib are oral JANUS kinase inhibitors (JAK). These drugs are used in rheumatoid ahritis.Tofacitinib is also used in ulcerative colitis. Major side-effects of these drugs are:* Increased risk of infection: TB , Herpes zoster.* Increased risk of malignancy like Lymphoma.* Hyperiglyceridemia.They require dose reduction in kidney and liver failure. So, they are avoided in lymphopenia and anemia.So, the answer is 'B' because it is not used in Crohn's disease.